Medication-Assisted Treatment Medication-Assisted Treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide a “whole-patient” approach to the treatment of substance use disorders. Research shows that a combination of medication and therapy can can help some people struggling with addiction sustain recovery. Treatment should include access to the medication-assisted treatment (MAT) options of methadone, buprenorphine, or extended-release naltrexone, which are effective for both prescription opioid and heroin addiction.
Drug scheduling also helps regulate how drug companies, pharmacies and prescribers manufacture and distribute controlled substances. The DEA can add, remove or change the schedules of drugs based on scientific evidence, but drug schedules must adhere to international treaties.
Schedule 2 (II) Drugs The drug has a high potential for abuse. The drug has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse of the drug may lead to severe psychological or physical dependence. The following drugs are listed as Schedule 2 (II) Drugs* by the Controlled Substances Act (CSA): The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.